Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Deepcell

Biotech & Life Sciences · Sunnyvale, United States · Founded 2015

Deepcell is a biotechnology startup that operates in the field of cell analysis and sorting. The company's primary product is the REM-I platform, a cutting-edge technology that combines label-free imaging, deep learning, and gentle sorting to analyze and categorize cells based on their morphology, or shape and structure. This technology allows for a high-dimensional quantitative readout, meaning it can provide detailed and comprehensive data about individual cells. Deepcell's technology is built on advanced microfluidics, a technique that manipulates tiny droplets of fluid in a controlled way, and artificial intelligence (AI). The AI component of the REM-I platform uses deep learning, a type of machine learning that mimics the workings of the human brain, to analyze and interpret the data gathered from the cell imaging. This combination of technologies allows for deep characterization of cells, providing valuable insights for researchers and scientists. The company's clients are likely to be in the scientific and medical research fields, where detailed cell analysis is crucial. For example, pharmaceutical companies developing new drugs, or academic researchers studying diseases at a cellular level, could benefit from Deepcell's technology. Deepcell's business model is likely based on selling or licensing its REM-I platform to these clients. The company may also generate revenue from providing data analytics services, using the powerful data gathered from its cell imaging technology to provide clients with detailed reports and insights. In summary, Deepcell is a biotech startup that uses advanced technology to provide detailed cell analysis and sorting services. Its combination of microfluidics, AI, and data analytics makes it a leader in its field, and its REM-I platform is likely to be in high demand among scientific and medical researchers. Keywords: Biotechnology, Cell Analysis, Cell Sorting, REM-I Platform, Microfluidics, Deep Learning, Artificial Intelligence, Data Analytics, Scientific Research, Medical Research.

Valuation
$100–500M
Latest valuation · 2022
Unlock exact value
Headcount
<100
Current team size
Unlock exact value
Total funding Pre-IPO
$100–500M
Unlock exact value

Investors

10 investors on Deepcell's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 9 investors entered at this stage
Jeff Dean
DCVC
Fifty Years
Bow Capital
Matt McIlwain
Bridger Healthcare
Horizons Ventures
Casdin Capital
Koch Disruptive Technologies

Global footprint

Where Deepcell has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States97.1%
🇭🇰 Hong Kong2.9%
2 countries shown

Talent graph

The shape of Deepcell's talent

Dealroom maps Deepcell's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

6 team members profilednamed & role-tagged by Dealroom
33 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Deepcell's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Deepcell

An AI-synthesized read of the highest-engagement posts about Deepcell on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Deepcell on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.